These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

996 related items for PubMed ID: 22281388

  • 21. Langmuir-Schaefer film deposition onto honeycomb porous films for retinal tissue engineering.
    Calejo MT, Ilmarinen T, Vuorimaa-Laukkanen E, Talvitie E, Hakola HM, Skottman H, Kellomäki M.
    Acta Biomater; 2017 May; 54():138-149. PubMed ID: 28223209
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW, Mahmoudzadeh R, Kuriyan AE.
    Stem Cell Res Ther; 2021 Oct 11; 12(1):538. PubMed ID: 34635174
    [Abstract] [Full Text] [Related]

  • 24. Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures.
    Hsiung J, Zhu D, Hinton DR.
    Stem Cells Transl Med; 2015 Jan 11; 4(1):10-20. PubMed ID: 25411476
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs.
    Koss MJ, Falabella P, Stefanini FR, Pfister M, Thomas BB, Kashani AH, Brant R, Zhu D, Clegg DO, Hinton DR, Humayun MS.
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug 11; 254(8):1553-1565. PubMed ID: 27335025
    [Abstract] [Full Text] [Related]

  • 28. A Preclinical Safety Study of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells for Macular Degeneration.
    Mazzilli JL, Snook JD, Simmons K, Domozhirov AY, Garcia CA, Wetsel RA, Zsigmond EM, Westenskow PD.
    J Ocul Pharmacol Ther; 2020 Aug 11; 36(1):65-69. PubMed ID: 31596637
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.
    Westenskow PD, Kurihara T, Friedlander M.
    Adv Exp Med Biol; 2014 Aug 11; 801():323-9. PubMed ID: 24664714
    [Abstract] [Full Text] [Related]

  • 31. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
    Kanemura H, Go MJ, Shikamura M, Nishishita N, Sakai N, Kamao H, Mandai M, Morinaga C, Takahashi M, Kawamata S.
    PLoS One; 2014 Aug 11; 9(1):e85336. PubMed ID: 24454843
    [Abstract] [Full Text] [Related]

  • 32. Iris pigment epithelial cell translocation in exudative age-related macular degeneration. A pilot study in patients.
    Lappas A, Weinberger AW, Foerster AM, Kube T, Rezai KA, Kirchhof B.
    Graefes Arch Clin Exp Ophthalmol; 2000 Aug 11; 238(8):631-41. PubMed ID: 11011682
    [Abstract] [Full Text] [Related]

  • 33. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial.
    Binder S, Krebs I, Hilgers RD, Abri A, Stolba U, Assadoulina A, Kellner L, Stanzel BV, Jahn C, Feichtinger H.
    Invest Ophthalmol Vis Sci; 2004 Nov 11; 45(11):4151-60. PubMed ID: 15505069
    [Abstract] [Full Text] [Related]

  • 34. Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium.
    Bennis A, Jacobs JG, Catsburg LAE, Ten Brink JB, Koster C, Schlingemann RO, van Meurs J, Gorgels TGMF, Moerland PD, Heine VM, Bergen AA.
    Stem Cell Rev Rep; 2017 Oct 11; 13(5):659-669. PubMed ID: 28730556
    [Abstract] [Full Text] [Related]

  • 35. Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degeneration.
    Giannakaki-Zimmermann H, Querques G, Munch IC, Shroff D, Sarraf D, Chen X, Cunha-Souza E, Mrejen S, Capuano V, Rodrigues MW, Gupta C, Ebneter A, Zinkernagel MS, Munk MR.
    BMC Ophthalmol; 2017 May 15; 17(1):67. PubMed ID: 28506260
    [Abstract] [Full Text] [Related]

  • 36. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR, Alten F, Termühlen J, Mihailovic N, Rosenberger F, Heiduschka P, Eter N.
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul 15; 258(7):1411-1417. PubMed ID: 32306096
    [Abstract] [Full Text] [Related]

  • 37. Timing of Peak Vision Gains in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab.
    Khurana RN, Chang L, Day BM, Ghanekar A, Stoilov I.
    Ophthalmol Retina; 2020 Aug 15; 4(8):760-766. PubMed ID: 32387055
    [Abstract] [Full Text] [Related]

  • 38. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
    Surendran H, Rathod RJ, Pal R.
    Methods Mol Biol; 2019 Aug 15; 2045():283-298. PubMed ID: 29896658
    [Abstract] [Full Text] [Related]

  • 39. ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.
    Croze RH, Buchholz DE, Radeke MJ, Thi WJ, Hu Q, Coffey PJ, Clegg DO.
    Stem Cells Transl Med; 2014 Sep 15; 3(9):1066-78. PubMed ID: 25069775
    [Abstract] [Full Text] [Related]

  • 40. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
    Bracha P, Moore NA, Ciulla TA.
    Expert Opin Biol Ther; 2017 Sep 15; 17(9):1113-1126. PubMed ID: 28664762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.